- 関
- CCK-A receptor
WordNet
- the 1st letter of the Roman alphabet (同)a
- the blood group whose red cells carry the A antigen (同)type_A, group A
- a cellular structure that is postulated to exist in order to mediate between a chemical agent that acts on nervous tissue and the physiological response
- a gastrointestinal hormone that stimulates the secretion of pancreatic enzymes and the contraction and emptying of the gall bladder; its release is stimulated by the presence of fatty acids and amino acids in the small intestine
PrepTutorEJDIC
- answer / ampere
- =sense organ / 受信装置
- arsenicの化学記号
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2015/12/12 20:23:11」(JST)
[Wiki en表示]
Cholecystokinin A receptor |
PDB rendering based on 1d6g.
|
Available structures |
PDB |
Ortholog search: PDBe, RCSB |
List of PDB id codes |
1D6G, 1HZN, 1PB2
|
|
|
Identifiers |
Symbols |
CCKAR ; CCK-A; CCK1-R; CCK1R; CCKRA |
External IDs |
OMIM: 118444 MGI: 99478 HomoloGene: 37337 IUPHAR: 76 ChEMBL: 1901 GeneCards: CCKAR Gene |
Gene ontology |
Molecular function |
• cholecystokinin receptor activity
• peptide binding
|
Cellular component |
• lysosome
• endosome
• endoplasmic reticulum
• cytosol
• plasma membrane
• integral component of plasma membrane
• terminal bouton
|
Biological process |
• temperature homeostasis
• gastric acid secretion
• neuron migration
• reduction of food intake in response to dietary excess
• phospholipase C-activating G-protein coupled receptor signaling pathway
• positive regulation of cytosolic calcium ion concentration
• axonogenesis
• response to nutrient
• digestion
• feeding behavior
• response to radiation
• response to heat
• insulin secretion
• pancreatic juice secretion
• forebrain development
• pancreas development
• organ regeneration
• actin cytoskeleton reorganization
• response to lipopolysaccharide
• cellular response to hormone stimulus
• cholecystokinin signaling pathway
• response to starvation
• regulation of potassium ion transport
• regulation of hormone secretion
• response to glucocorticoid
• regulation of calcium ion transport
• positive regulation of somatostatin secretion
• response to peptide
|
Sources: Amigo / QuickGO |
|
RNA expression pattern |
|
|
More reference expression data |
Orthologs |
Species |
Human |
Mouse |
Entrez |
886 |
12425 |
Ensembl |
ENSG00000163394 |
ENSMUSG00000029193 |
UniProt |
P32238 |
O08786 |
RefSeq (mRNA) |
NM_000730 |
NM_009827 |
RefSeq (protein) |
NP_000721 |
NP_033957 |
Location (UCSC) |
Chr 4:
26.48 – 26.49 Mb |
Chr 5:
53.7 – 53.71 Mb |
PubMed search |
[1] |
[2] |
|
Cholecystokinin A receptor, N-terminal domain |
molecular complex of cholecystokinin-8 and n-terminus of the cholecystokinin a receptor by nmr spectroscopy
|
Identifiers |
Symbol |
CholecysA-Rec_N |
Pfam |
PF09193 |
InterPro |
IPR015276 |
SCOP |
1d6g |
SUPERFAMILY |
1d6g |
Available protein structures: |
Pfam |
structures |
PDB |
RCSB PDB; PDBe; PDBj |
PDBsum |
structure summary |
|
The Cholecystokinin A receptor is a human protein, also known as CCKAR or CCK1, with CCK1 now being the IUPHAR-recommended name.
This gene encodes a G-protein coupled receptor that binds non-sulfated members of the cholecystokinin (CCK) family of peptide hormones. This receptor is a major physiologic mediator of pancreatic enzyme secretion and smooth muscle contraction of the gallbladder and stomach. In the central and peripheral nervous system this receptor regulates satiety and the release of beta-endorphin and dopamine.[1]
The extracellular, N-terminal, domain of this protein adopts a tertiary structure consisting of a few helical turns and a disulfide-cross linked loop. It is required for interaction of the cholecystokinin A receptor with its corresponding hormonal ligand.[2]
Contents
- 1 Selective Ligands
- 1.1 Agonists
- 1.2 Antagonists
- 2 See also
- 3 References
- 4 External links
- 5 Further reading
Selective Ligands
Agonists
- Cholecystokinin
- Gastrin
- CCK-4
- SR-146,131
- A-71623 - modified tetrapeptide, potent and selective CCKA agonist, IC50 3.7nM, 1200x selectivity over CCKB, CAS# 130408-77-4
Antagonists
- Proglumide
- Lorglumide
- Devazepide
- Dexloxiglumide
- Asperlicin
- SR-27897
- IQM-95333
- JNJ-17156516
See also
- Cholecystokinin receptor
- Cholecystokinin antagonist
References
- ^ "Entrez Gene: CCKAR cholecystokinin A receptor".
- ^ Pellegrini M, Mierke DF (November 1999). "Molecular complex of cholecystokinin-8 and N-terminus of the cholecystokinin A receptor by NMR spectroscopy". Biochemistry 38 (45): 14775–83. doi:10.1021/bi991272l. PMID 10555959.
External links
- "Cholecystokinin Receptors: CCK1". IUPHAR Database of Receptors and Ion Channels. International Union of Basic and Clinical Pharmacology.
Further reading
- Varga G, Bálint A, Burghardt B, D'Amato M (2004). "Involvement of endogenous CCK and CCK1 receptors in colonic motor function.". Br. J. Pharmacol. 141 (8): 1275–84. doi:10.1038/sj.bjp.0705769. PMC 1574909. PMID 15100163.
- Wang J, Si YM, Liu ZL, Yu L. (2003). "Cholecystokinin, cholecystokinin-A receptor and cholecystokinin-B receptor gene polymorphisms in Parkinson's disease.". Pharmacogenetics 13 (6): 365–9. PMID 12777967.
- Miller LJ, Holicky EL, Ulrich CD, Wieben ED (1995). "Abnormal processing of the human cholecystokinin receptor gene in association with gallstones and obesity.". Gastroenterology 109 (4): 1375–80. doi:10.1016/0016-5085(95)90601-0. PMID 7557108.
- Huppi K, Siwarski D, Pisegna JR, Wank S (1995). "Chromosomal localization of the gastric and brain receptors for cholecystokinin (CCKAR and CCKBR) in human and mouse.". Genomics 25 (3): 727–9. doi:10.1016/0888-7543(95)80018-H. PMID 7759110.
- de Weerth A, Pisegna JR, Huppi K, Wank SA (1993). "Molecular cloning, functional expression and chromosomal localization of the human cholecystokinin type A receptor.". Biochem. Biophys. Res. Commun. 194 (2): 811–8. doi:10.1006/bbrc.1993.1894. PMID 8343165.
- Ulrich CD, Ferber I, Holicky E; et al. (1993). "Molecular cloning and functional expression of the human gallbladder cholecystokinin A receptor.". Biochem. Biophys. Res. Commun. 193 (1): 204–11. doi:10.1006/bbrc.1993.1610. PMID 8503909.
- Kennedy K, Gigoux V, Escrieut C; et al. (1997). "Identification of two amino acids of the human cholecystokinin-A receptor that interact with the N-terminal moiety of cholecystokinin.". J. Biol. Chem. 272 (5): 2920–6. doi:10.1074/jbc.272.5.2920. PMID 9006937.
- Inoue H, Iannotti CA, Welling CM; et al. (1997). "Human cholecystokinin type A receptor gene: cytogenetic localization, physical mapping, and identification of two missense variants in patients with obesity and non-insulin-dependent diabetes mellitus (NIDDM).". Genomics 42 (2): 331–5. doi:10.1006/geno.1997.4749. PMID 9192855.
- Gigoux V, Escrieut C, Silvente-Poirot S; et al. (1998). "Met-195 of the cholecystokinin-A receptor interacts with the sulfated tyrosine of cholecystokinin and is crucial for receptor transition to high affinity state.". J. Biol. Chem. 273 (23): 14380–6. doi:10.1074/jbc.273.23.14380. PMID 9603948.
- Funakoshi A, Fukamizu Y, Miyasaka K (2000). "Mechanism of cholecystokinin-A- receptor antagonist on human pancreatic exocrine secretion. Localization of CCK-A receptor in the human duodenum.". Digestion. 60 Suppl 1: 75–80. doi:10.1159/000051459. PMID 10026437.
- Gigoux V, Escrieut C, Fehrentz JA; et al. (1999). "Arginine 336 and asparagine 333 of the human cholecystokinin-A receptor binding site interact with the penultimate aspartic acid and the C-terminal amide of cholecystokinin.". J. Biol. Chem. 274 (29): 20457–64. doi:10.1074/jbc.274.29.20457. PMID 10400673.
- Gigoux V, Maigret B, Escrieut C; et al. (2000). "Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.". Protein Sci. 8 (11): 2347–54. doi:10.1110/ps.8.11.2347. PMC 2144185. PMID 10595537.
- Funakoshi A, Miyasaka K, Matsumoto H; et al. (2000). "Gene structure of human cholecystokinin (CCK) type-A receptor: body fat content is related to CCK type-A receptor gene promoter polymorphism.". FEBS Lett. 466 (2–3): 264–6. doi:10.1016/S0014-5793(00)01080-2. PMID 10682840.
- Tachikawa H, Harada S, Kawanishi Y; et al. (2000). "Novel polymorphisms of the human cholecystokinin A receptor gene: an association analysis with schizophrenia". Am. J. Med. Genet. 96 (2): 141–5. doi:10.1002/(SICI)1096-8628(20000403)96:2<141::AID-AJMG3>3.0.CO;2-R. PMID 10893485.
- Giragossian C, Mierke DF (2001). "Intermolecular interactions between cholecystokinin-8 and the third extracellular loop of the cholecystokinin A receptor". Biochemistry 40 (13): 3804–9. doi:10.1021/bi002659n. PMID 11300760.
- Schmitz F, Schrader H, Otte J; et al. (2002). "Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells". Regul. Pept. 101 (1–3): 25–33. doi:10.1016/S0167-0115(01)00281-6. PMID 11495676.
- Tachikawa H, Harada S, Kawanishi Y; et al. (2002). "Linked polymorphisms (-333G>T and -286A>G) in the promoter region of the CCK-A receptor gene may be associated with schizophrenia". Psychiatry Research 103 (2–3): 147–55. doi:10.1016/S0165-1781(01)00276-1. PMID 11549403.
- Schmitz F, Göke MN, Otte JM; et al. (2002). "Cellular expression of CCK-A and CCK-B/gastrin receptors in human gastric mucosa". Regul. Pept. 102 (2–3): 101–10. doi:10.1016/S0167-0115(01)00307-X. PMID 11730982.
- Okubo T, Harada S, Higuchi S, Matsushita S (2003). "Investigation of quantitative trait loci in the CCKAR gene with susceptibility to alcoholism". Alcohol. Clin. Exp. Res. 26 (8 Suppl): 2S–5S. doi:10.1097/01.ALC.0000026826.96191.FB. PMID 12198366.
- Takata Y, Takeda S, Kawanami T; et al. (2003). "Promoter analysis of human cholecystokinin type-A receptor gene". J. Gastroenterol. 37 (10): 815–20. doi:10.1007/s005350200135. PMID 12424565.
This article incorporates text from the United States National Library of Medicine, which is in the public domain.
PDB gallery
|
|
|
1d6g: MOLECULAR COMPLEX OF CHOLECYSTOKININ-8 AND N-TERMINUS OF THE CHOLECYSTOKININ A RECEPTOR BY NMR SPECTROSCOPY
|
|
|
|
Neuropeptide receptors
|
|
G protein-coupled receptor |
Hormone receptors |
Hypothalamic |
- CRH
- FSH
- LHRH
- TRH
- Somatostatin
|
|
Pituitary |
- Vasopressin
- Oxytocin
- LHCG
- TSH
|
|
Other |
- Atrial natriuretic factor
- Calcitonin
- Cholecystokinin
- VIP
|
|
|
Opioid receptors |
- Delta
- Kappa
- Mu
- Nociceptin
|
|
Other neuropeptide receptors |
- Angiotensin
- Bradykinin
- Tachykinin
- Calcitonin gene-related peptide
- Galanin
- GPCR neuropeptide
- Neurotensin
|
|
|
Type I cytokine receptor |
|
|
Enzyme-linked receptor |
- Atrial natriuretic factor
|
|
Other |
|
|
Index of signal transduction
|
|
Description |
- Intercellular
- neuropeptides
- growth factors
- cytokines
- hormones
- Cell surface receptors
- ligand-gated
- enzyme-linked
- G protein-coupled
- immunoglobulin superfamily
- integrins
- neuropeptide
- growth factor
- cytokine
- Intracellular
- adaptor proteins
- GTP-binding
- MAP kinase
- Calcium signaling
- Lipid signaling
- Pathways
- hedgehog
- Wnt
- TGF beta
- MAPK ERK
- notch
- JAK-STAT
- apoptosis
- hippo
- TLR
|
|
|
Neuropeptidergics
|
|
CGRP |
- Agonists: Amylin
- CGRP
- Pramlintide
- Antagonists: BI 44370 TA
- BMS-927711
- CGRP (8-37)
- MK-3207
- Olcegepant
- Rimegepant
- SB-268262
- Telcagepant
- Ubrogepant
|
|
Cholecystokinin |
CCKA
|
- Agonists: Cholecystokinin
- CCK-4
- Antagonists: Amiglumide
- Asperlicin
- Devazepide
- Dexloxiglumide
- Lintitript
- Lorglumide
- Loxiglumide
- Pranazepide
- Proglumide
- Tarazepide
- Tomoglumide
|
|
CCKB
|
- Agonists: Cholecystokinin
- CCK-4
- Gastrin
- Antagonists: CI-988 (PD-134,308)
- Itriglumide
- L-365,360
- Netazepide
- Proglumide
- Spiroglumide
|
|
Unsorted
|
- Antagonists: Nastorazepide
|
|
|
CRH |
CRF1
|
- Agonists: Cortagine
- Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Stressin I
- Urocortin
- Antagonists: Antalarmin
- Astressin-B
- CP-154,526
- Emicerfont
- Hypericin
- LWH-234
- NBI-27914
- Pexacerfont
- R-121,919
- TS-041
- Verucerfont
|
|
CRF2
|
- Agonists: Corticorelin
- Corticotropin releasing hormone
- Sauvagine
- Urocortin
|
|
|
Galanin |
GAL1
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin-like peptide
- Galmic
- Galnon
- Antagonists: C7
- Dithiepine-1,1,4,4-tetroxide
- Galantide (M15)
- M32
- M35
- M40
- SCH-202596
|
|
GAL2
|
- Agonists: Galanin
- Galanin (1-15)
- Galanin (2-11)
- Galanin-like peptide
- Galmic
- Galnon
- J18
- Antagonists: C7
- Galantide (M15)
- M32
- M35
- M40
- M871
|
|
GAL3
|
- Agonists: Galanin
- Galanin (1-15)
- Galmic
- Galnon
- Antagonists: C7
- Galantide (M15)
- GalR3ant
- HT-2157
- M32
- M35
- M40
- SNAP-37889
- SNAP-398299
|
|
|
Ghrelin/GHS |
- Agonists: Adenosine
- Alexamorelin
- Anamorelin
- Capromorelin
- CP-464709
- Cortistatin-14
- Examorelin (hexarelin)
- Ghrelin (lenomorelin)
- GHRP-1
- GHRP-3
- GHRP-4
- GHRP-5
- GHRP-6
- Ibutamoren (MK-677)
- Ipamorelin
- L-692,585
- LY-426410
- LY-444711
- Macimorelin
- Pralmorelin (GHRP-2)
- Relamorelin
- SM-130,686
- Tabimorelin
- Ulimorelin
- Antagonists: A-778,193
- Cortistatin-8
- (D-Lys3)-GHRP-6
- YIL-781
|
|
MCH |
MCH1
|
- Agonists: Melanin concentrating hormone
- Antagonists: ATC-0065
- ATC-0175
- GW-803,430
- NGD-4715
- SNAP-7941
- SNAP-94847
|
|
MCH2
|
- Agonists: Melanin concentrating hormone
|
|
|
Melanocortin |
MC1
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- BMS-470,539
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- PL-8177
- SHU-8914
- SHU-9005
- SHU-9119
- SNAP-7941
|
|
MC2
|
- Agonists: ACTH (corticotropin)
- Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
MC3
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- Melanotan II
- Modimelanotide
- PG-931
- Antagonists: AGRP
- ASIP
- HS-014
- ML-00253764
- PG-106
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC4
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- AZD2820
- BIM-22493
- Bremelanotide
- LY-2112688
- Melanotan II
- MK-0493
- Modimelanotide
- PF-00446687
- PG-931
- PL-6983
- Ro 27-3225
- Setmelanotide
- THIQ
- Antagonists: AGRP
- ASIP
- HS-014
- HS-024
- HS-131
- JKC-363
- MCL-0020
- MCL-0042
- MCL-0129
- ML-00253764
- MPB-10
- SHU-8914
- SHU-9005
- SHU-9119
|
|
MC5
|
- Agonists: α-MSH
- β-MSH
- γ-MSH
- ACTH (corticotropin)
- Afamelanotide
- Bremelanotide
- HS-014
- HS-024
- Melanotan II
- Modimelanotide
- SHU-8914
- SHU-9005
- SHU-9119
- Antagonists: ASIP
- ML-00253764
|
|
Unsorted
|
- Agonists: Alsactide
- Codactide
- Giractide
- Norleusactide (pentacosactride)
- Seractide
- Tetracosactide (tetracosactrin, cosyntropin)
- Tosactide (octacosactrin)
- Tricosactide
- Tridecactide
|
|
|
Neuropeptide FF |
- Agonists: Neuropeptide AF
- Neuropeptide FF
- Neuropeptide SF (RFRP-1)
- Neuropeptide VF (RFRP-3)
- Antagonists: BIBP-3226
- RF9
|
|
Neuropeptide S |
- Antagonists: ML-154
- SHA-68
|
|
Neuropeptide Y |
Y1
|
- Agonists: Neuropeptide Y
- Peptide YY
- Antagonists: BIBO-3304
- BIBP-3226
- BVD-10
- GR-231,118
- PD-160,170
|
|
Y2
|
- Agonists: 2-Thiouridine 5'-triphosphate
- Neuropeptide Y
- Neuropeptide Y (13-36)
- Peptide YY
- Peptide YY (3-36)
- Antagonists: BIIE-0246
- JNJ-5207787
- SF-11
|
|
Y4
|
- Agonists: GR-231,118
- Neuropeptide Y
- Pancreatic polypeptide
- Peptide YY
|
|
Y5
|
- Agonists: BWX-46
- Neuropeptide Y
- Peptide YY
- Antagonists: CGP-71683
- FMS-586
- L-152,804
- Lu AA-33810
- MK-0557
- NTNCB
- Velneperit (S-2367)
|
|
|
Neurotensin |
NTS1
|
- Agonists: Neurotensin
- Neuromedin N
- Antagonists: Meclinertant
- SR-142,948
|
|
NTS2
|
- Antagonists: Levocabastine
- SR-142,948
|
|
|
Opioid |
See here instead.
|
|
Orexin |
OX1
|
- Agonists: Orexin-A
- Orexin-B
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- Filorexant
- Lemborexant
- SB-334,867
- SB-408,124
- SB-649,868
- Suvorexant
- TCS-1102
|
|
OX2
|
- Agonists: Orexin-A
- Orexin-B
- SB-668,875
- Antagonists: ACT-335827
- ACT-462206
- Almorexant
- EMPA
- Filorexant
- JNJ-10397049
- JNJ-42847922
- Lemborexant
- MK-1064
- SB-649,868
- Suvorexant
- TCS-1102
- TCS-OX2-29
|
|
|
Oxytocin |
- Agonists: Aspartocin
- Carbetocin
- Cargutocin
- Demoxytocin
- Lipo-oxytocin-1
- Merotocin
- Nacartocin
- Oxytocin
- TC OT 39
- TGOT
- Vasotocin (argiprestocin)
- WAY-267,464
- Antagonists: Atosiban
- Barusiban
- Epelsiban
- Erlosiban
- L-368,899
- L-371,257
- L-372,662
- OBE001
- Retosiban
- SSR-126,768
- Tocinoic acid
- WAY-162,720
- Metabolism inhibitors: Amastatin
- Bestatin (ubenimex)
- EDTA
- L-Methionine
- Leupeptin
- o-Phenanthroline
- Phosphoramidon
- Puromycin
|
|
Tachykinin |
NK1
|
- Antagonists: Aprepitant
- Befetupitant
- Burapitant
- Casopitant
- CI-1021
- CP-96,345
- CP-99,994
- CP-122,721
- Dapitant
- Ezlopitant
- Figopitant
- FK-888
- Fosaprepitant
- Fosnetupitant
- GR-203,040
- GW-597,599
- HSP-117
- L-733,060
- L-741,671
- L-743,310
- L-758,298
- Lanepitant
- LY-306,740
- Maropitant
- Netupitant
- NKP-608
- Nolpitantium besilate
- Orvepitant
- Rolapitant
- RP-67,580
- SDZ NKT 343
- Serlopitant
- Telmapitant
- Tradipitant
- Vestipitant
- Vofopitant
|
|
NK2
|
- Antagonists: GR-159,897
- Ibodutant
- Nepadutant
- Saredutant
|
|
NK3
|
- Antagonists: Osanetant
- Talnetant
|
|
|
Vasopressin |
V1A
|
- Agonists: Felypressin
- Lypressin
- Ornipressin
- Selepressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Atosiban
- Conivaptan
- FR-218944
- JNJ-17079166
- JNJ-17308616
- LY-307174
- PF-184563
- Relcovaptan
- RG7314
- SRX246
- SRX251
- TC OT 39
- WAY-267,464
- YM-218
- YM-471
- YM-35471
|
|
V1B
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: ABT-436
- Nelivaptan
- ORG-52186
|
|
V2
|
- Agonists: Desmopressin
- Felypressin
- Lypressin
- Ornipressin
- TC OT 39
- Terlipressin
- Vasopressin (argipressin)
- Vasotocin (argiprestocin)
- Antagonists: Conivaptan
- JNJ-17079166
- Lixivaptan
- Mozavaptan
- RWJ-351647
- Satavaptan
- Tolvaptan
- YM-471
- YM-35471
|
|
Unsorted
|
- Antagonists: Ribuvaptan
- RWJ-339489
- VMAX-367
- VMAX-372
- VMAX-382
- YM-222546
|
|
|
See also: Peptidergics
|
|
This article incorporates text from the public domain Pfam and InterPro IPR015276
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Transmembrane helix: simple or complex.
- Wong WC, Maurer-Stroh S, Schneider G, Eisenhaber F.SourceBioinformatics Institute (BII), Agency for Science, Technology and Research (A STAR), 30 Biopolis Street, #07-01, Matrix, Singapore 138671. wongwc@bii.a-star.edu.sg
- Nucleic acids research.Nucleic Acids Res.2012 Jul;40(Web Server issue):W370-5. doi: 10.1093/nar/gks379. Epub 2012 May 7.
- Transmembrane helical segments (TMs) can be classified into two groups of so-called 'simple' and 'complex' TMs. Whereas the first group represents mere hydrophobic anchors with an overrepresentation of aliphatic hydrophobic residues that are likely attributed to convergent evolution in many cases, t
- PMID 22564899
- Cholecystokinin receptor-1 mediates the inhibitory effects of exogenous cholecystokinin octapeptide on cellular morphine dependence.
- Wen D, Ma CL, Zhang YJ, Meng YX, Ni ZY, Li SJ, Cong B.SourceDepartment of Forensic Medicine, Hebei Medical University, Hebei Key Laboratory of Forensic Medicine, Shijiazhuang 050017, PR China.
- BMC neuroscience.BMC Neurosci.2012 Jun 8;13:63. doi: 10.1186/1471-2202-13-63.
- BACKGROUND: Cholecystokinin octapeptide (CCK-8), the most potent endogenous anti-opioid peptide, has been shown to regulate the processes of morphine dependence. In our previous study, we found that exogenous CCK-8 attenuated naloxone induced withdrawal symptoms. To investigate the precise effect of
- PMID 22682150
Japanese Journal
- Cellular and subcellular localization of cholecystokinin (CCK)-1 receptors in the pancreas, gallbladder, and stomach of mice
- 発育関連遺伝子を指標とした地頭鶏の選抜試験(第1報)
- コレシストキニンA受容体遺伝子g.420 C>A一塩基多型は比内鶏の発育を改善する
Related Links
- protein gene tissue distribution preferred ligand function CCK A (CCK 1) CCKAR primarily gastrointestinal tract, lesser amounts in the CNS sulfated CCK >> nonsulfated CCK ≈ nonsulfated CCK stimulation of bicarb secretion, gall ...
- Species, Scientific Experts, Genomes and Genes, Research Grants, Publications, Research Topics about cholecystokinin a receptor ... Summary: A subtype of cholecystokinin receptor found primarily in the PANCREAS ...
★リンクテーブル★
[★]
- 関
- cholecystokinin A receptor
[★]
- 英
- cholecystokinin A receptor、CCK-A receptor
- 関
- コレシストキニンAレセプター、CCK-A受容体、CCK-Aレセプター
[★]
- 英
- cholecystokinin A receptor、CCK-A receptor
- 関
- コレシストキニンA受容体、CCK-A受容体、CCK-Aレセプター
[★]
[★]
- 関
- adenoviral、adenovirus
[★]
コレシストキニン CCK